After opening the day on a flat note, Indian share markets witnessed negative trading activity as the session progressed and ended lower.
Benchmark indices fell ahead of domestic retail inflation data due later in the day while the ongoing uncertainty and spillover effects from the Adani group's rout continued to create an overhang.
At the closing bell, the BSE Sensex stood lower by 251 points (down 0.4%).
Meanwhile, the NSE Nifty closed lower by 85 points (down 0.5%).
Titan, L&T, and NTPC were among the top gainers today.
Adani Enterprises, Adani port, and SBI on the other hand, were among the top losers today.
The SGX Nifty was trading at 17,789, down by 88 points, at the time of writing.
Broader markets settled on a negative note. The BSE Midcap ended 1.3% lower while the BSE SmallCap index ended 1.2% lower.
Sectoral indices ended on a mixed note with stocks in the industrial sector and capital goods sector witnessing buying.
While stocks in the IT sector, realty sector, and power sector witnessed selling.
Shares of Jindal Saw, Cera Sanitary, and APL Apollo Tubes hit their 52-week highs today.
To know about the stocks which moved the markets, check out the stocks to watch today section on our website.
Asian share markets ended the day on a mixed note. The Hang Seng index fell 0.1%, while the Shanghai Composite index rose 0.7%. The Nikkei fell 0.9%.
US stock futures are trading on a mixed note. Dow futures are trading lower by 0.1% while Nasdaq futures are up 0.2%.
The rupee is trading at 82.74 against the US$.
Gold prices for the latest contract on MCX are trading flat at Rs 56,700 per 10 grams.
Meanwhile, silver prices for the latest contract on MCX are trading down by 0.6% at Rs 66,255 per kg.
Speaking of stock markets, Brijesh Bhatia talks about a trading technique that can boost your gains in his latest video.
In the video below, he shows a technique that is effective for making higher gains from trading stocks called pyramiding.
Also, to understand what our readers are thinking about the India's growth story, we recently conducted a poll on our telegram channel and here are the results:
With over 1,000 responses from the participants till this morning, most of the readers think that the India's rise is unstoppable.
Three Adani group companies have pledged additional shares for State Bank of India, days after a scathing report by a US short-seller led to over US$ 100 billion (bn) loss in its market value.
Adani Ports and Special Economic Zone (APSEZ), Adani Transmission and Adani Green Energy pledged shares to SBICAP Trustee Company, a unit of India's biggest lender, SBI.
According to filings, as many as 0.8 million (m) more shares of Adani Ports have been pledged, taking the total to 1% of all shares with SBICAP. In the case of Adani Green pledge of 0.6 m more shares took the total to 1.1%. A pledge of 0.1 m more shares of Adani Transmission took the total to 0.55%.
Following the pledge and the group reducing its revenue target, Adani group stocks cracked up to 10% in intraday trade today.
All 10 Adani stocks were trading with a negative bias, with most locked in their lower circuit limits.
To know whether it is time to buy the dip in the Adani Group stocks, check our editorial: Adani Group stocks: should you catch this falling knives?
Moving on to news from the pharma sector, shares of Natco Pharma jumped 5% in intraday trade.
This rally comes after the company filed a generic version of an oncology drug in the US markets.
The drug major filed an abbreviated new drug application (ANDA) for generic versions of Olaparib tablets - 100 mg and 150 mg with the US Food and Drug Administration (USFDA). Olaparib is used to treat ovarian, breast, pancreatic, and prostate cancer.
Since Olaparib tablets are marketed in the US by AstraZeneca, under the brand Lynparza, the pharma major informed that it was named as a defendant in a lawsuit filed by AstraZeneca and Kudos Pharmaceuticals.
That said, NATCO and its co-development marketing partner Alembic Pharmaceuticals believe that ANDA's first-to-file basis could make the company eligible for 180 days of marketing exclusivity at the time of the launch of the product.
As per AstraZeneca, Lynparza recorded sales of US$ 1,226 m in the US market for the year ended December 2022.
Check out Equitymaster's stock screener for screening India's top pharma stocks.
Moving on to news from the steel sector, shares of JSW Steel were in focus today.
JSW Steel, on Monday, reported a 15% YoY rise in crude steel production at 1.8 m tons in January.
The company's crude steel production was at 1.6 m tons in January 2022. This is the highest-ever crude steel production for the month reported by the company.
The production of its flat-rolled products increased by 14% to 1.4 m tons over 1.2 m tons in January 2022.
Its output of long-rolled products also registered a growth of 14% to 0.4 m tons, against 0.3 m tons in January 2022.
The overall capacity utilization was higher at 99% in January 2023 from 96% in December 2022.
JSW Steel is the flagship business of the diversified USD 22 billion JSW Group, which also has business interests in sectors such as energy, infrastructure, cement, paints, sports and venture capital.
While several steel companies are set to benefit from government aims to boost this industry, two well-known private players will also benefit from the growth of this industry. They are Tata Steel and JSW Steel.
To know which of the two stocks is better, check out Tata Steel vs JSW Steel: which stock is better?
And to know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Today Falls 251 Points Ahead of Inflation Data | Adani Group Stocks Bleed | SBI, Infosys Among Top Losers". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!